Chaohu Chen - Publications

TIMP1 Derived from Mesenchymal Stem Cells Promotes Bladder Cancer Progression by Regulating the Formation of VDIMs through the RAP1 Pathway.

Journal: International journal of biological sciences

Published: December 30, 2025

The clinical efficacy of novel semirigid ureteroscopy with a vacuum suction device for treatment of >10 mm upper ureteral stones and impacted calculus: implications for clinical practice.

Journal: Frontiers in surgery

Published: June 30, 2025

Autophagy-related biological targets and network mechanisms of juglone against bladder cancer.

Journal: Journal of cancer research and clinical oncology

Published: April 07, 2025

Development and preclinical evaluation of a novel FGFR3-targeted antibody-drug conjugate in bladder cancer.

Journal: Asian journal of pharmaceutical sciences

Published: February 28, 2025

Comparative study on the efficacy of low-dose and full-dose BCG bladder perfusion therapy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 27, 2024

Effect of smoking on the recurrence and progression of non-muscle-invasive bladder cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 08, 2024

FL118: A potential bladder cancer therapeutic compound targeting H2A.X identified through library screening.

Journal: Bioorganic chemistry

Published: June 24, 2024

Knockdown of AMIGO2 suppresses proliferation and migration through regulating PPAR-γ in bladder cancer.

Journal: Hereditas

Published: September 15, 2023

Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis.

Journal: BMC cancer

Published: June 14, 2023

CAB39 promotes cisplatin resistance in bladder cancer via the LKB1-AMPK-LC3 pathway.

Journal: Free radical biology & medicine

Published: April 15, 2023

ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 14, 2022

Homologous Recombination Related Signatures Predict Prognosis and Immunotherapy Response in Metastatic Urothelial Carcinoma.

Journal: Frontiers in genetics

Published: February 14, 2022